Pay in 4 interest-free payments of $2.99 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Part 54 - Financial Disclosure by Clinical Investigators
Frequently Asked Questions for Combination Products
The 600+ page GCP Master Handbook is a complete reference library for the clinical professional
- Chapter 3 - Premise and Equipment
ICH E8 (R1) General Considerations for Clinical Studies
21 CFR 312, 314, 511 - Human and Animal Drug Approval 11 Part 54 - Financial DisclosureUS FDA Title 21 CFR Parts: Part 312 Investigational New Drug Application Part 314 Applications for FDA Approval to Market a New Drug Part 511 New Animal Drugs for Investigational Use
US$ 25.00
US$ 20.00
US$ 12.00
US$ 16.00
US$ 68.00
